Biocept, Inc. (BIOC)
(Delayed Data from NSDQ)
$0.91 USD
+0.01 (1.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $0.91 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
BIOC 0.91 +0.01(1.10%)
Will BIOC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BIOC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BIOC
Assure Holdings Corp. (IONM) Reports Q3 Loss, Lags Revenue Estimates
Agiliti (AGTI) Q3 Earnings Surpass Estimates
BIOC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sotera Health Company (SHC) Q3 Earnings and Revenues Surpass Estimates
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Lags Revenue Estimates
HealthEquity (HQY) Misses Q2 Earnings Estimates